Cameco Corporation $CCJ Shares Purchased by Goehring & Rozencwajg Associates LLC

Goehring & Rozencwajg Associates LLC grew its stake in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 5.3% during the fourth quarter, Holdings Channel reports. The firm owned 682,952 shares of the basic materials company’s stock after purchasing an additional 34,663 shares during the period. Cameco makes up approximately 6.0% of Goehring & Rozencwajg Associates LLC’s investment portfolio, making the stock its 4th largest position. Goehring & Rozencwajg Associates LLC’s holdings in Cameco were worth $62,483,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Clearstead Advisors LLC lifted its position in shares of Cameco by 0.8% during the 4th quarter. Clearstead Advisors LLC now owns 10,158 shares of the basic materials company’s stock worth $929,000 after buying an additional 85 shares during the last quarter. Legacy Bridge LLC lifted its position in shares of Cameco by 0.9% during the 4th quarter. Legacy Bridge LLC now owns 11,508 shares of the basic materials company’s stock worth $1,053,000 after buying an additional 100 shares during the last quarter. S.A. Mason LLC lifted its position in shares of Cameco by 4.8% during the 4th quarter. S.A. Mason LLC now owns 2,436 shares of the basic materials company’s stock worth $223,000 after buying an additional 111 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Cameco by 19.9% during the 4th quarter. GAMMA Investing LLC now owns 676 shares of the basic materials company’s stock worth $62,000 after buying an additional 112 shares during the last quarter. Finally, Kingsview Wealth Management LLC lifted its position in shares of Cameco by 3.4% during the 4th quarter. Kingsview Wealth Management LLC now owns 3,435 shares of the basic materials company’s stock worth $314,000 after buying an additional 114 shares during the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CCJ. Weiss Ratings downgraded shares of Cameco from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Scotiabank reiterated an “outperform” rating and issued a $175.00 price objective on shares of Cameco in a research note on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on Cameco from $150.00 to $160.00 and gave the company an “outperform” rating in a research note on Tuesday, February 17th. William Blair initiated coverage on Cameco in a research note on Monday, April 20th. They issued an “outperform” rating for the company. Finally, Barclays initiated coverage on Cameco in a research note on Thursday, May 21st. They issued an “equal weight” rating and a $108.00 price objective for the company. Eleven equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $148.62.

Cameco Trading Up 2.0%

NYSE:CCJ opened at $100.94 on Friday. The firm has a market cap of $43.96 billion, a P/E ratio of 93.47, a PEG ratio of 1.68 and a beta of 0.99. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14. The stock’s 50 day simple moving average is $113.12 and its 200-day simple moving average is $109.09. Cameco Corporation has a 12-month low of $64.84 and a 12-month high of $135.24.

Cameco (NYSE:CCJ) (TSE:CCO) last released its earnings results on Tuesday, May 5th. The basic materials company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. The business had revenue of $607.49 million for the quarter, compared to analyst estimates of $598.63 million. Cameco had a return on equity of 11.05% and a net margin of 18.38%.The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 earnings per share. Equities analysts anticipate that Cameco Corporation will post 1.31 EPS for the current year.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long?term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.